Hologic CFO reports 1,333-share tax withholding in Form 4
Hologic Inc. Chief Financial Officer Form 4 filing details insider share activity.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Hologic Inc. Chief Financial Officer Form 4 filing details insider share activity. On 11/14/2025, the CFO reported the disposition of 1,333 shares of Hologic common stock at $74.15 per share, labeled as shares withheld to cover tax obligations related to the settlement of previously granted restricted stock units whose service-based vesting conditions were satisfied.
After this tax withholding transaction, the CFO beneficially owns 150,735 shares in total. This figure includes 41,121 restricted stock units and performance stock units whose settlement has been deferred under Hologic’s Deferred Equity Plan.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 1,333 | $74.15 | $99K |
Footnotes (2)
- F1. Shares withheld for tax obligations in connection with the settlement of restricted stock units for which service-based vesting requirements have been satisfied.
- F2. Includes 41,121 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to the Issuer's Deferred Equity Plan.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Hologic (HOLX) report in this Form 4?
The Form 4 reports that Hologic’s Chief Financial Officer disposed of 1,333 shares of common stock on 11/14/2025 at $74.15 per share, with the shares withheld to satisfy tax obligations tied to vested restricted stock units.
Who is the reporting person in the Hologic (HOLX) Form 4 and what is their role?
The reporting person in this Form 4 is Hologic’s Chief Financial Officer, who is identified as an Officer of the company rather than a director or 10% owner.
What are the 41,121 units mentioned in the Hologic (HOLX) Form 4 footnote?
The filing explains that the total beneficial ownership includes 41,121 restricted stock units and performance stock units, with settlement deferred under Hologic’s Deferred Equity Plan.
Is this Hologic (HOLX) Form 4 filing for one reporting person or multiple?
The filing indicates that it is a Form filed by one reporting person, specifically the company’s Chief Financial Officer.
AI-generated analysis. How Rhea-AI works. Not financial advice.